- Home
- NIM vs SRTS Comparison
NIM vs SRTS Comparison
Compare NIM & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIM
- SRTS
- Stock Information
- Founded
- NIM 1992
- SRTS 2010
- Country
- NIM United States
- SRTS United States
- Employees
- NIM N/A
- SRTS N/A
- Industry
- NIM Trusts Except Educational Religious and Charitable
- SRTS Medical/Dental Instruments
- Sector
- NIM Finance
- SRTS Health Care
- Exchange
- NIM Nasdaq
- SRTS Nasdaq
- Market Cap
- NIM 116.7M
- SRTS 106.0M
- IPO Year
- NIM N/A
- SRTS 2016
- Fundamental
- Price
- NIM $9.32
- SRTS $6.82
- Analyst Decision
- NIM
- SRTS Strong Buy
- Analyst Count
- NIM 0
- SRTS 2
- Target Price
- NIM N/A
- SRTS $10.00
- AVG Volume (30 Days)
- NIM 35.4K
- SRTS 91.0K
- Earning Date
- NIM 01-01-0001
- SRTS 11-07-2024
- Dividend Yield
- NIM 3.46%
- SRTS N/A
- EPS Growth
- NIM N/A
- SRTS 179.87
- EPS
- NIM N/A
- SRTS 0.41
- Revenue
- NIM N/A
- SRTS $36,366,000.00
- Revenue This Year
- NIM N/A
- SRTS $54.75
- Revenue Next Year
- NIM N/A
- SRTS $22.06
- P/E Ratio
- NIM N/A
- SRTS $16.71
- Revenue Growth
- NIM N/A
- SRTS 20.99
- 52 Week Low
- NIM $8.28
- SRTS $1.79
- 52 Week High
- NIM $9.74
- SRTS $7.18
- Technical
- Relative Strength Index (RSI)
- NIM 53.64
- SRTS 64.76
- Support Level
- NIM $9.24
- SRTS $6.28
- Resistance Level
- NIM $9.34
- SRTS $6.80
- Average True Range (ATR)
- NIM 0.06
- SRTS 0.30
- MACD
- NIM -0.00
- SRTS 0.08
- Stochastic Oscillator
- NIM 53.00
- SRTS 96.64
About NIM Nuveen Select Maturities Municipal Fund
Nuveen Select Maturities Municipal Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with the preservation of capital by investing in an investment-grade quality portfolio of municipal obligations with intermediate characteristics.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.